CardioMEMS: the next revolution in heart failure management?

por Handoko, M. L., van de Bovenkamp, A. A.
Publicado 2019

TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention...

por van de Bovenkamp, A. A., Bakermans, A. J., Allaart, C. P., Nederveen, A. J., Kok, W. E. M., van Rossum, A. C., Handoko, M. L.
Publicado 2020